New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 15, 2012
13:44 EDTDVAXFDA panel votes against backing Dynavax's Heplisav, Bloomberg reports
An FDA panel voted against recommending approval of Dynavax's hepatitis B vaccine Heplisav, saying the company provided inadequate safety data, Bloomberg reports.
News For DVAX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 21, 2014
17:25 EDTDVAXAmici Capital reports 7.45% passive stake in Dynavax
November 10, 2014
17:15 EDTDVAXDynavax files $200M mixed securities shelf
06:07 EDTDVAXDynavax announces DSMB recommendation to continue HEPLISAV-B Phase 3 study
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use